4518 Metabolomic Identifiers Predictive of Adverse Events due to Acetaminophen Administration

4518 Metabolomic Identifiers Predictive of Adverse Events due to Acetaminophen Administration

OBJECTIVES/GOALS: Acetaminophen (Tylenol, APAP) toxicity has been well documented and well explored over the last 50 years. However, there has been no investigation into identification of specific metabolites that can predict which patients will have adverse reactions to therapeutic doses of APAP. M...

Full description

Bibliographic Details
Main Authors:	Brandon Joseph Sonn, Kennon Heard, Andrew Monte
Format:	Article
Language:	English
Published:	Cambridge University Press 2020-06-01
Series:	Journal of Clinical and Translational Science
Online Access:	https://www.cambridge.org/core/product/identifier/S2059866120003374/type/journal_article

Similar Items

Oral and Intravenous Acetylcysteine for Treatment of Acetaminophen Toxicity: A Systematic Review and Meta-analysis
by: Donald Albert, et al.
Published: (2013-05-01)

4521 Collecting, Interpreting and Utilizing Retrospective Clinical Data from Data Warehouses
by: Brandon Joseph Sonn, et al.
Published: (2020-06-01)

Preferences of patients undergoing hemodialysis – results from a questionnaire-based study with 4,518 patients
by: Janssen IM, et al.
Published: (2015-06-01)

Acetaminophen-cysteine adducts during therapeutic dosing and following overdose
by: Judge Bryan S, et al.
Published: (2011-03-01)

LncRNA SNHG16 Functions as an Oncogene by Sponging MiR-4518 and Up-Regulating PRMT5 Expression in Glioma
by: Ye-Fen Lu, et al.
Published: (2018-03-01)

Another Perspective on Cannabis and Emergency Medicine in Colorado
by: Kennon Heard, et al.
Published: (2019-10-01)

Attribution of Adverse Events Following Coronary Stent Placement Identified Using Administrative Claims Data
by: Sanket S. Dhruva, et al.
Published: (2020-02-01)

Potential adverse actions of prenatal exposure of acetaminophen to offspring
by: Ka Wu, et al.
Published: (2023-04-01)

Metabolomics Approach for Validation of Self-Reported Ibuprofen and Acetaminophen Use
by: Kristine K. Dennis, et al.
Published: (2018-09-01)

Author correction to “Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors” [Acta Pharmaceutica Sinica B 12 (2022) 4501–4518]
by: Yuling Mao, et al.
Published: (2024-03-01)

Metabolomics Analysis of Urine Samples from Children after Acetaminophen Overdose
by: Laura K. Schnackenberg, et al.
Published: (2017-09-01)

Developing a cancer‐specific trigger tool to identify treatment‐related adverse events using administrative data
by: Saul N. Weingart, et al.
Published: (2020-02-01)

Alteration in Metabolism and Toxicity of Acetaminophen Upon Repeated Administration in Rats
by: Sun J. Kim, et al.
Published: (2009-01-01)

Is There a Causal Relation between Maternal Acetaminophen Administration and ADHD?
by: Antonio Saad, et al.
Published: (2016-01-01)

Testing of Candidate Icons to Identify Acetaminophen-Containing Medicines
by: Saul Shiffman, et al.
Published: (2016-01-01)

META-INSTI: metabolic adverse events following integrase strand transfer inhibitor administration in spontaneous adverse event reports
by: Milena M Murray, et al.
Published: (2023-08-01)

Automatically Recognizing Medication and Adverse Event Information From Food and Drug Administration’s Adverse Event Reporting System Narratives
by: Polepalli Ramesh, Balaji, et al.
Published: (2014-06-01)

Adverse events associated with molnupiravir: a real-world disproportionality analysis in food and drug administration adverse event reporting system
by: Yankun Liang, et al.
Published: (2023-10-01)

Erratum to ‘Adverse Local Tissue Reaction Due to Acetabular Corrosion in Modular Dual-Mobility Constructs’ [Arthroplasty Today 6 (2020) 976-980]
by: Kevin A. Sonn, MD, et al.
Published: (2022-06-01)

The juniper bush of autism spectrum disorder (ASD): metabolomics, microbiomics, acetaminophen. What else?
by: Vassilios Fanos, et al.
Published: (2018-05-01)

Predicting adverse outcomes due to diabetes complications with machine learning using administrative health data
by: Mathieu Ravaut, et al.
Published: (2021-02-01)

Adverse events following administration of COVID-19 vaccines in Saudi Arabia
by: Saleh Alqahtani, et al.
Published: (2022-11-01)

Adverse events related to medication administration in a Taquari Valley hospital
by: Kellen Cristina Januário Benedetti Alves, et al.
Published: (2020-01-01)

Validating administrative data for the detection of adverse events in older hospitalized patients
by: Ackroyd-Stolarz S, et al.
Published: (2014-08-01)

Adverse Events Following Administration of Anti-CTLA4 Antibody Ipilimumab
by: Amirali Karimi, et al.
Published: (2021-03-01)

Generation and characterization of an induced pluripotent stem cell line (FJMUNi001-A) from a patient with Duchenne muscular dystrophy carrying c.4518 + 512 T > A variant in the DMD gene
by: Ming Jin, et al.
Published: (2022-04-01)

Psoriasis adverse events and associated medications as reported in the US Food and Drug Administration’s Adverse Event Reporting System from 2016 to 2021
by: Christine Learned, BA, et al.
Published: (2022-06-01)

Efficacy of a Single Dose Administration of Ibuprofen and Acetaminophen in Comparison with Acetaminophen for the Relief of Perineal Pain after Childbirth: A randomized controlled trial
by: Preeyaporn Harasai, et al.
Published: (2020-01-01)

Effect of Pu-erh tea on acetaminophen-induced hepatotoxicity assessed by physiological, metabolomic, and transcriptomic analyses
by: Xinxin Cao, et al.
Published: (2022-05-01)

Targeted metabolomic profiling indicates structure-based perturbations in serum phospholipids in children with acetaminophen overdose
by: Sudeepa Bhattacharyya, et al.
Published: (2016-01-01)

Non-Invasive Predictive Biomarkers for Immune-Related Adverse Events Due to Immune Checkpoint Inhibitors
by: Ben Ponvilawan, et al.
Published: (2024-03-01)

Acetaminophen for analgesia following pyloromyotomy: does the route of administration make a difference?
by: Yung A, et al.
Published: (2016-03-01)

Oral acetaminophen administration for patent ductus arteriosus (PDA) closure in preterm neonates
by: Mahmood Samadi, et al.
Published: (2021-08-01)

Rheumatic and Musculoskeletal Adverse Events with Immune Checkpoint Inhibitors: Data from the United States Food and Drug Administration Adverse Event Reporting System
by: Xerxes N Pundole, et al.
Published: (2019-07-01)

Adverse event profiles of solvent-based and nanoparticle albumin-bound paclitaxel formulations using the Food and Drug Administration Adverse Event Reporting System
by: Misa Naganuma, et al.
Published: (2019-03-01)

Potential Adverse Drug Events with Tetrahydrocannabinol (THC) Due to Drug–Drug Interactions
by: Joshua D. Brown
Published: (2020-03-01)

TO DISCONTINUE OR TO WAIT?: INDICATIONS FOR DISCONTINUATION OF ANTI-TUBERCULOSIS DRUGS DUE TO ADVERSE EVENTS
by: D. A. Ivаnovа, et al.
Published: (2018-03-01)

The high incidence of severe adverse events due to pyrazinamide in elderly patients with tuberculosis.
by: Byoung Soo Kwon, et al.
Published: (2020-01-01)

HOSPITALIZATIONS DUE TO ADVERSE DRUG EVENTS IN THE ELDERLY – A RETROSPECTIVE REGISTER STUDY
by: Outi Laatikainen, et al.
Published: (2016-10-01)

On the safety of acetaminophen
by: R. N. Alyautdin, et al.
Published: (2022-06-01)